Surgery – Diagnostic testing – Measuring or detecting nonradioactive constituent of body...
Patent
1998-07-23
2000-10-03
Gilbert, Samuel G.
Surgery
Diagnostic testing
Measuring or detecting nonradioactive constituent of body...
600506, 600547, A61B 505
Patent
active
061285188
ABSTRACT:
The hematocrit of blood (i.e., the percentage of whole blood volume occupied by red blood cells) perfusing a finger is determined by stimulating the finger with two current frequencies, one relatively high (e.g., 10 MHZ) and the other relatively low (e.g., 100 KHz). Voltages induced in the finger in response to the two current frequencies are then captured and separated into baseline and pulsatile components. The hematocrit is determined as a function of the ratio of the high frequency pulsatile component to the low frequency pulsatile component, multiplied by the ratio of the square of the low frequency baseline component to the square of the high frequency baseline component. The signal-to-noise ratio of the captured voltages can be enhanced by the application of external pressure to the finger, such as by applying a pressure cuff to the finger.
REFERENCES:
patent: 5111817 (1992-05-01), Clark et al.
patent: 5277181 (1994-01-01), Mendelson et al.
patent: 5526808 (1996-06-01), Kaminsky
patent: 5642734 (1997-07-01), Ruben et al.
Billings Robert Gail
Clark Justin S.
Kaminsky Allan L.
Neese Jon
Yang Ke-shieng
Carter Ryan
Gilbert Samuel G.
Microcor, Inc.
LandOfFree
System and method for in-vivo hematocrit measurement using imped does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with System and method for in-vivo hematocrit measurement using imped, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and System and method for in-vivo hematocrit measurement using imped will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-203883